Salta al contenuto principale
vitamin D and cancer

Vitamin D could cut risk of dying from cancer

Taking vitamin D supplements could help cancer patients live longer, according to new research.

Video picks for Vitamine e integratori

Vitamina D carries significant benefits beyond contributing to healthy bones. Researchers found taking a daily supplement for at least three years could cut the risk of dying of all cancers by 13%. However, there was no evidence that taking vitamin D pills could prevent the disease in the first place.

Dr Tarek Haykal, lead author on the study and an internal medicine resident physician at Michigan State University and Hurley Medical Centre said: "Vitamin D had a significant effect on lowering the risk of death among those with cancer, but unfortunately it didn't show any proof that it could protect against getting cancer."

Every two minutes someone in the UK is diagnosed with cancro and the disease accounts for over a quarter of deaths in the country.

To reach their conclusions, the Michigan team looked at data from more than 79,000 patients in multiple studies that compared the use of vitamin D to placebo over at least three years.

"The difference in the mortality rate between the vitamin D and placebo groups was statistically significant enough that it showed just how important it might be among the cancer population," Haykal said.

These findings are promising - not least because vitamin D supplements carry minimal side effects - but more research is needed before we understand how much of the vitamin is needed, why it has this effect of longevity, and for how much longer supplements might extend someone's life.

"All we can say is that at least three years of taking the supplement is required to see any effect. We know it carries benefits with minimal side effects. There's plenty of potential here," concluded Haykal.

The research is published in the Journal of Clinical Oncology.

Continua a leggere sotto

About the authorView full bio

Author image

Natalie Healey

Freelance journalist

BSc (Hons) Biomedical Science

She is a London-based health journalist who has been writing about science and medicine for several years. She is the former head of editorial at Patient.

About the reviewerView full bio

Author image

Natalie Healey

Freelance journalist

BSc (Hons) Biomedical Science

She is a London-based health journalist who has been writing about science and medicine for several years. She is the former head of editorial at Patient.

Storia dell'articolo

Le informazioni su questa pagina sono revisionate da clinici qualificati.

verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

verificatore di sintomi

Non ti senti bene?

Valuta i tuoi sintomi online gratuitamente

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

By subscribing you accept our Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.